Tumor Therapeutics Enhance Tumor Sensitivity to NK Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6. J Biol Chem. 2015;290:29964.

Science

Works on an Innovative Immunotherapeutic Approach Against

Cancer, Virus Infection and Autoimmune Diseases

Home > Science > Tumor Therapeutics Enhance Tumor Sensitivity to NK Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6. J Biol Chem. 2015;290:29964.

Science

Tumor Therapeutics Enhance Tumor Sensitivity to NK Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6. J Biol Chem. 2015;290:29964.

2015-10-15

share:

ICP备字：皖ICP备2022011087号-1 （皖）-非经营性-2022-0075 皖公网安备 34019102001077号 ©Copyright by TGI All rights reserved.

网站技术支持：网新科技

Legal Statement Privacy Policy Terms Of Use